Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Propofol based TIVA versus inhalational anesthesia and colorectal cancer recurrence, a prospective randomized study

ABSTRACT: Interventions: I group;Group T Primary outcome(s): 1-year cancer free survival Study Design: Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously,Randomised,Simple randomization using a randomization table created by a computer software program,Sealed opaque envelopes

DISEASE(S): Anaesthesia,Cancer

PROVIDER: 2507893 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

The influence of Isoflurane versus combined isoflurane - epidural anesthesia on the immune response in patients undergoing surgery for colorectal canc

Project description:Interventions: isoflurane group;isoflurane-epidural group Primary outcome(s): interleukins IL-6 , IL-10 Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,simple randomisation using a randomisation table created by a computer software program,Sealed opaque envelopes

| 2505810 | ecrin-mdr-crc

ultrasound guided ERAS

Project description:Interventions: ultrasound ERAS;ERAS Primary outcome(s): Period of Hospital stay Study Design: Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously,Randomised,closed envelop technique,Sealed opaque envelopes

| 2506600 | ecrin-mdr-crc

The impact of pre-operative education on post-operative outcomes in patients with colorectal cancer in Johannesburg, South Africa

Project description:Interventions: Control group;Intervention group one;Intervention group two Primary outcome(s): ICU length of stay;Survival;Hospital length of stay;Post-operative complications Study Design: Factorial: participants randomly allocated to either no, one, some or all interventions simultaneously,Randomised,Stratified allocation where factors such as age, gender, center, or previous treatment are used in the stratification,Sealed opaque envelopes

| 2507080 | ecrin-mdr-crc

Evaluation of the therapeutic effect of crocin along with standard regimes in colorectal cancer

Project description:Intervention 1: Intervention group: Crocin along with standard regime will be assigned to intervention group. The daily dose of crocin will be 30 mg (two 15 mg tablets) during 12 weeks. Intervention 2: Control group: The treatment regimen is with Folfiri, Folfox or Xelox and also placebo without Targeted therapy. Primary outcome(s): Overall survival. Timepoint: One year after the treatment is completed. Method of measurement: Patient follow-up. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random allocation rule.This study with a sample size of 100 people, 50 balls for the placebo group and 50 balls for the intervention group are placed in a container and then the balls are randomly selected without replacement, Blinding description: Sequentially numbered, sealed, opaque envelopes. A random sequence is created by random allocation rule. Then, based on the sample size, 100 envelopes with aluminum foil inside (to prevent ‘’hot lighting’’) are prepared. Each entity in the random sequence is noted on a card and are replaced in numbered envelop. Finally, the envelopes are sealed and placed in boxes, respectively. The envelops are respectively assigned to each participant so the participant’s assigned group is revealed.

| 2481925 | ecrin-mdr-crc

A study of colorectal cancer in a referral center

Project description:Primary outcome(s): To evaluate the demography and clinical presentation CRC patientsTimepoint: 5 years follow up for survival Study Design: Other Method of generating randomization sequence:Coin toss, Lottery, toss of dice, shuffling cards etc Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2580595 | ecrin-mdr-crc

Effect of a drug (Oral Ivabradine) on BP and Heart Rate during putting endotracheal tube with laryngoscopy.

Project description:Intervention1: Tablet Ivabradine: Oral Ivabradine 5mg was given one hour before surgery Control Intervention1: tablet multivitamin: oral multivitamin(one tablet) one hour before surgery Primary outcome(s): Haemodynamics changesTimepoint: up to 10 min after laryngoscopy and intubation Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 2757961 | ecrin-mdr-crc

Does local application of nitrates, during insertion of staplers via anal canal for bowel anastomosis prevent injury to muscles of anal canal ?

Project description:Intervention1: 0.2% Glyceryl Trinitrate: 1mg 0.2% glyceryl trinitrate, which corresponds to 2cm on the standardized measuring scale Control Intervention1: Nil: Nil Primary outcome(s): To compare anal sphincter pressure between intervention and observation groupsTimepoint: 1-3 days preoperative and 14-30 days postoperative Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2579582 | ecrin-mdr-crc

Comparison of pain in patient under going major surgery under general anaesthesia vs general and Epidural anaesthesia

Project description:Intervention1: General anaesthesia and epidural anesthesia vs only general anaesthesia and periopertive analgesia: 0-3-6-12-24hr Dose of ropivacaine 0.3/cc @4ml/hr acc to pt profile dose will be increased Control Intervention1: General anaesthesia only and periopertive analgesia: 0-3-6-12-24hr Primary outcome(s): Vas score assessment and need for inhalation agent perioperative periodTimepoint: 0-3-6-12-24hr Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2715133 | ecrin-mdr-crc

Comparison of intubation using instruments as Ambu Auragain,fastrach LMA and Blockbuster LMA.

Project description:Intervention1: Tracheal intubation with supraglottic Airway devices: Comparison of tracheal intubation with Ambu AuraGain,fastrach Laryngeal Mask and Blockbuster Laryngeal Mask Airway. Control Intervention1: Ambu AuraGain: Tracheal intubation with Ambu AuraGain Control Intervention2: Fastrach Laryngeal Mask Airway: Tracheal intubation with Fastrach Laryngeal Mask Airway. Control Intervention3: Blockbuster Laryngeal Mask Airway: Tracheal intubation with Blockbuster Laryngeal Mask Airway. Primary outcome(s): First Attempt success rate of tracheal intubation.Timepoint: During intubation Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

| 2605805 | ecrin-mdr-crc

Comparison of two drugs ( inj dexmedetomidine and inj clonidine) in terms of recovery from anaesthesia

Project description:Intervention1: Dexmedetomidine and Clonidine: Drugs to be given before the end of surgery as infusion over 10 minutes Control Intervention1: Injection Dexmedetomidine: Injection Dexmedetomidine 1 Microgram / Kg at the end of surgery as infusion over 10 minutes Control Intervention2: Injection Clonidine: Injection Clonidine 3 Microgram /Kg as infusion over 10 minutes at the end of surgery Primary outcome(s): Haemodynamic stabilityTimepoint: Intraoperatively (1- 3 hours) Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

| 29486 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data